An Evaluation of the Expectancy Value Model of Attitude Measurement for Physician Prescribing Behavior

Harrell, Gilbert D.; Bennett, Peter

doi:10.2307/3151142

Cited by 46 publications

(9 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Possible mean range 1 to 49, neutral = 16. Intenders ( ); Non-intenders ( ) Table 5 Respondents' composite attitude score by practice setting Influence of attitudes on pharmacists' intention to report ADEs successfully used to predict physician prescribing and reporting behaviour [51,63] and pharmacists' reporting behaviour [64]. Vignettes and hypothetical cases may be effective in predicting pharmacists' reporting of serious ADEs.…”

Section: Figurementioning

confidence: 99%

Influence of attitudes on pharmacists' intention to report serious adverse drug events to the Food and Drug Administration

Gavaza¹,

Brown²,

Lawson³

et al. 2011

Brit J Clinical Pharma

View full text Add to dashboard Cite

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT• Attitude is an important factor impacting pharmacists' reporting of adverse drug events (ADE) to pharmacovigilance centres. • However, little is known about United States (US) pharmacists' attitudes with respect to ADE reporting. No known study has assessed US pharmacists' attitude to report serious ADEs to the FDA. WHAT THIS STUDY ADDS• This study results suggest that pharmacists hold favourable attitudes toward reporting serious ADEs to the FDA and there is an association between pharmacists' attitude and intention to report serious ADEs.• Pharmacists' beliefs that reporting serious ADEs was time consuming and disrupted the normal workflow impact on reporting intentions.• Pharmacists' attitudes towards reporting need to be improved in order to enhance patient and drug safety. AIMTo investigate the influence of pharmacists' attitudes on intention to report serious adverse drug events (ADEs) to the Food and Drug Administration (FDA). METHODSThis cross-sectional study used a mail survey to collect data from hospital and community pharmacists practicing in Texas, United States. Three and 16 items were used to measure intention and attitudes, respectively, using a seven-point bipolar scale. Pharmacists' demographic and practice characteristics, and past reporting were also measured. RESULTSThe response rate was 26.4% (n = 377/1500 pharmacists). Most pharmacists intended (n = 297, 78.8%) to report serious ADEs that they will encounter to the FDA through MedWatch. Overall, pharmacists held favourable attitudes towards reporting serious ADEs (mean = 24.5, SD = 6.7, possible range 1-49, neutral = 16). Pharmacists intending to report serious ADEs had more favourable attitudes than those who did not (P < 0.001). About 90% of the pharmacists believed that reporting serious ADEs would improve patient safety. However, 72.6% indicated that reporting serious ADEs was time consuming and over half (55.5%) of the respondents believed that reporting serious ADEs disrupted the normal workflow. Non-intenders held stronger beliefs that ADE reporting would disrupt the normal workflow and was time consuming compared with intenders. Years of experience, number of hours worked and practice setting were associated with pharmacists' attitudes towards reporting (P < 0.05). CONCLUSIONSMost pharmacists held moderately favourable attitudes and high intentions toward reporting serious ADEs to the FDA. This study's findings contribute to an increased understanding of individual factors that influence pharmacists' attitude and intention towards reporting serious ADEs to the FDA.

show abstract

Section: Figurementioning

confidence: 99%

Influence of attitudes on pharmacists' intention to report serious adverse drug events to the Food and Drug Administration

Gavaza¹,

Brown²,

Lawson³

et al. 2011

Brit J Clinical Pharma

View full text Add to dashboard Cite

show abstract

“…For physician's prescriptions, in the "expectancy-value" model, expectancies about treatment outcomes and the value or desirability of those outcomes in explaining drug choices is compared (Segal and Hepler, 1982). Although normative factors also included expectancies, these expectancies are related to professional acceptability and patient demands (Harrell and Bennet, 1974;Epstein et al, 1984). Denig et al (1988) attempted to identify the contribution of values and norms in the prescription behavior model.…”

Section: Literature Reviewmentioning

confidence: 99%

Prescription loyalty behavior of physicians: an empirical study in India

Abdul

Jaleel²,

Laeequddin³

2011

International Journal of Pharmaceutical and Healthcare Marketing

View full text Add to dashboard Cite

Purpose -This paper seeks to empirically identify the major factors that influence physician loyalty behavior in prescribing certain brands of drugs. Design/methodology/approach -Testable hypotheses were developed with respect to physician loyalty behavior regarding drug prescription practices, and a survey questionnaire was designed to capture the data from 71 physicians, as a convenience sample. The hypotheses were tested by PLS path modeling. Findings -The major finding is that tangible rewards to physicians by the pharmaceutical companies lead to prescription loyalty. The second major finding is that the professional values of pharmaceutical sales representatives (PSR) impact significantly on physician prescription loyalty. The hypotheses related to the impact of PSR personality, drug quality, corporate reputation and professional influence on prescription loyalty were not supported in the study.Practical implications -The results should prove useful to pharmaceutical companies in developing physician loyalty to particular brands as well as enhancing the understanding of drug control authorities and governmental health policy makers, in controlling unethical medical practices by physicians. Originality/value -This paper reports an original empirical study on physician loyalty behavior in the context of drug prescription.

show abstract

“…426-427) and since the neutral response (neither agree nor disagree) may be considered a natural origin, the authors believe it is reasonable to treat responses to the Likert scales as quasi-ratio data. There is precedent for this approach in the literature (e.g., Harrell and Bennett 1974).…”

Section: Description Of the Instrumentmentioning

confidence: 99%